Jesús Porta-Etessam to Immunosuppressive Agents
This is a "connection" page, showing publications Jesús Porta-Etessam has written about Immunosuppressive Agents.
Connection Strength
0.113
-
Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal. J Med Virol. 2021 01; 93(1):546-549.
Score: 0.057
-
Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab. Mult Scler Relat Disord. 2020 Sep; 44:102297.
Score: 0.056